According to health experts, a ground-breaking new study could shift the terrain of future heart and lung treatments. The Covid-RV study was led by scientists from NHS Golden Jubilee as well as the University of Glasgow, who were investigating the impacts of COVID-19 on individuals in Intensive Care Units (ICU).
The study, which was the first of its type, looked at 121 critically ill patients in ten ICUs across Scotland, with the goal of learning more about the effects of COVID-19 on the sickest patients requiring invasive breathing. The study discovered that one out of every three individuals had anomalies in the right atrium of the heart, which delivers blood to the lungs.
A confluence of things creates a perfect storm for COVID-19 to damage the right side of your heart, which can ultimately cause death, said Honorary clinical senior lecturer at the University of Glasgow as well as Consultant in Cardiothoracic Anaesthesia and Intensive Care at NHS Golden Jubilee, Dr Philip McCall. If blood is getting pumped to the lungs and the lungs are sick, there is an added complication because the lungs won’t take blood.
Unless one is especially looking for it, this is a very tough condition to see. That is why the findings of this research are so crucial. COVID-19 is now recognised to be an issue that affects not only breathing but also the heart.
The research was finished in six months and three weeks, which is much faster than typical research of this type. The study has shown that there is no doubt COVID-19 impacts the heart and has a big impact on patient outcomes, stated Dr. Ben Shelley, Chief Investigator of the study and Consultant in Anaesthesia and Intensive Care at NHS Golden Jubilee. However, now that it is known that this happens and one has a greater understanding of how it impacts patients, one can plan ahead and implement new treatment plans and therapies to assist combat it.
Ultrasound scans, for example, can be used in a variety of ways to zero in on advance warning indications and places that are known to be in danger. If one can detect these warning signs early enough, clinicians will be able to investigate the reasons for any issues and begin new therapies as soon as possible, ultimately improving outcomes for COVID-19’s sickest patients.
Knowledge like this is crucial not only in combating future waves of COVID-19 but also in considering future pandemics so patients may be treated more efficiently. These findings also contain a number of intriguing areas that could be explored further to aid in the treatment of various lung disorders in general.
